Dimdazenil
(Redirected from EVT-201)
A benzodiazepine derivative
Dimdazenil | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Dimdazenil is a benzodiazepine derivative that has been studied for its potential use as an anxiolytic and anticonvulsant agent. It is a partial agonist at the benzodiazepine receptor site on the GABA_A receptor, which is the primary inhibitory neurotransmitter receptor in the central nervous system.
Pharmacology
Dimdazenil acts as a partial agonist at the benzodiazepine site of the GABAA receptor. This action enhances the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at this receptor, leading to increased neuronal inhibition and producing sedative, anxiolytic, and anticonvulsant effects. Unlike full agonists, partial agonists like dimdazenil may produce fewer side effects such as sedation and muscle relaxation, making them potentially useful in clinical settings where these effects are undesirable.
Clinical Use
While dimdazenil has shown promise in preclinical studies, it is not currently approved for clinical use. Research has focused on its potential to treat anxiety disorders and epilepsy, but further studies are needed to fully understand its efficacy and safety profile.
Chemical Properties
Dimdazenil is chemically classified as a benzodiazepine derivative. Its chemical structure includes a chlorine atom at the 8-position and a 2-chlorophenyl group, which are believed to contribute to its pharmacological activity. The presence of these groups may influence its binding affinity and selectivity for the benzodiazepine receptor.
Synthesis
The synthesis of dimdazenil involves the formation of the imidazo[2,1-b][3]benzazepin-5-one core structure, followed by the introduction of the chloro substituents. The specific synthetic route can vary, but typically involves multi-step organic synthesis techniques common in the production of benzodiazepine derivatives.
Potential Advantages
As a partial agonist, dimdazenil may offer advantages over traditional benzodiazepines, such as a lower risk of tolerance and dependence. This could make it a safer alternative for long-term use in treating chronic conditions like anxiety and epilepsy.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD